Growing revenues and profits and a full order book: these are the half-year results approved today by the board of directors of Ima, world leader in packaging machinery for pharmaceutical, cosmetic, tea, coffee and food products.
At 30 June 2013 consolidated revenues amounted to 327,5 million (+10% on the first half of 2012); gross operating margin (EBITDA) rises to 42,2 million (+20,2%), operating profit (EBIT) reaches 33,7 million (+25,7%) and profit before taxes i 30,8, 36,9 million (+XNUMX%).
The consolidated order book also grew (444,8 million), up 20,2% "thanks to the finalization - reads a note from the Bologna-based group - of numerous negotiations in the core businesses".
The results are the result of the favorable trend in sales to the pharmaceutical and food industries and an increase in margins in the various areas of intervention.
At the same time, debt decreased from 209,6 million to 143,5 million, also "thanks to the sale of the Stephan business", while a further reduction is expected for the end of the year by virtue of the "closing of the operation relating to Kilian ”.
On the basis of these premises, Ima sees growth throughout 2013: "revenues growing to approximately 760 million (743 million in 2012) and an Ebitda of approximately 105 million (101,4 million in 2012)".
The president Alberto Vacchi is satisfied: “also due to the constant growth of the consolidated order portfolio, which exceeds 60% of the turnover forecast for the current year and the good trend of orders, growing also in the month of July. These data confirm the validity of the strategic choices implemented in the last three years and the success of the products destined for the pharmaceutical and food sectors. Among our objectives - he adds - is to continue to create innovation, proposing solutions capable of anticipating the demands of a constantly evolving market and to continue on our growth path, generating value for shareholders and investors".
